Pneumococcal Adult and At Risk Vaccination Programme 2026/28
Pneumococcal Adult and At Risk Vaccination Programme – CSU Collaborative
Purpose and outline
This programme delivers vaccinations for patients aged 65 or over and at-risk patients aged 10 years to 64 years inclusive. Pneumococcal vaccines protect against pneumococcal infections. Invasive pneumococcal disease is a major cause of morbidity and mortality; whilst it can affect anyone, it particularly affects the very young, the elderly and those with impaired immunity or chronic conditions.
The Pneumococcal Polysaccharide Vaccine PPV23 will be replaced with Pneumococcal Conjugate Vaccine PCV20 once existing stocks have depleted, which is estimated to be during 2026.
PPV23 and PCV20 are the only vaccines routinely recommended for the patients eligible under this programme (PCV13 is offered to children as part of the Routine Immunisation schedules) and only one dose is usually required per patient which usually provides life-time cover. For a small number of at-risk patients, vaccination every five years is required.
How this service is commissioned and provided
Region’s commission this service from GP practices.
2026/28: Information about this service
Quality service start date: 1 April 2026
Quality service end date: 31 March 2028
Payment period: Monthly
Collection frequency: Monthly
Manual or automatic entry: Automatic data collection
Included in data collection: All system suppliers (TPP, Medicus and EMIS)
System type: Vaccination and Immunisation (V&I)
Service user guides
The below links to user guides describe how to participate, manually enter and declare achievement for this service:
Viewing, accepting and rejecting a Quality service offered in CQRS National